A Study of REGN5678 with Cemiplimab in Patients with Metastatic Castration Resistant Prostate Cancer (R5678-ONC-1879)
A Study of REGN5678 with Cemiplimab in Patients with Metastatic Castration Resistant Prostate Cancer (R5678-ONC-1879)
Trial Category:
Genitourinary
Phase
I
Contact(s)
Location(s)
Nebraska Cancer Specialists, Omaha, NE
